Abnormal methylation status of FBXW10 and SMPD3, and associations with clinical characteristics in clear cell renal cell carcinoma.
about
New Progress of Epigenetic Biomarkers in Urological CancerBelinostat exerts antitumor cytotoxicity through the ubiquitin-proteasome pathway in lung squamous cell carcinomaAberrant Promoter Methylation of PCDH17 (Protocadherin 17) in Serum and its Clinical Significance in Renal Cell Carcinoma.Combined Treatment with Valproic Acid and 5-Aza-2'-Deoxycytidine Synergistically Inhibits Human Clear Cell Renal Cell Carcinoma Growth and Migration.
P2860
Abnormal methylation status of FBXW10 and SMPD3, and associations with clinical characteristics in clear cell renal cell carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Abnormal methylation status of ...... ear cell renal cell carcinoma.
@ast
Abnormal methylation status of ...... ear cell renal cell carcinoma.
@en
type
label
Abnormal methylation status of ...... ear cell renal cell carcinoma.
@ast
Abnormal methylation status of ...... ear cell renal cell carcinoma.
@en
prefLabel
Abnormal methylation status of ...... ear cell renal cell carcinoma.
@ast
Abnormal methylation status of ...... ear cell renal cell carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Abnormal methylation status of ...... ear cell renal cell carcinoma.
@en
P2093
P2860
P304
P356
10.3892/OL.2015.3707
P577
2015-09-16T00:00:00Z